GBLX OTC
GB Sciences, Inc.
1W: -50.0%
1M: -66.7%
3M: -66.7%
YTD: -80.0%
1Y: -50.0%
3Y: -98.9%
5Y: -99.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$976K
+36.1% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$976K
+37.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$98K
+21.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$12M | -$4M | -$915K | -$4M | -$1M |
| Depreciation & Amort. | $259K | $47K | $70K | $62K | $624 |
| Stock-Based Comp. | $287K | $436K | $61K | $17K | $219K |
| Change in Working Capital | $4M | -$271K | $69K | $85K | $403K |
| Other Non-Cash Items | $1M | $1M | -$1M | -$20.2B | -$237K |
| Operating Cash Flow | -$4M | -$2M | -$2M | -$2M | -$976K |
| — Investing Activities — | |||||
| Capital Expenditures | -$294K | -$293K | -$200K | -$32K | $0 |
| Acquisitions (Net) | $0 | $0 | $2M | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$245K | $5M | $2K | $0 | $320K |
| Investing Cash Flow | -$539K | $5M | $1M | -$32K | $320K |
| — Financing Activities — | |||||
| Net Debt Issuance | $3M | -$2M | -$525K | -$49K | $322K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1M | -$269K | -$110K | $0 | $0 |
| Financing Cash Flow | $5M | -$1M | -$496K | $1M | $558K |
| Net Change in Cash | -$30K | $641K | -$912K | -$124K | -$98K |
| Cash End of Period | $152K | $793K | $234K | $110K | $12K |
| Free Cash Flow | -$5M | -$2M | -$2M | -$2M | -$976K |